Studies have shown that in hepatoma cells, HULC activates the promoter of Acyl-CoA synthetase long-chain family member1 (ACSL1) by upregulating the transcription factor PPARA, thus regulating lipid metabolism and promoting the proliferation of hepatoma cells [19]. Here, ACSL1 is linked to hepatocellular carcinoma.